Michael Gelband’s Trueblue TBI Stock Holding History

Michael Gelband’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-72,460	Closed	-$746K	–	2075
2024 Q2	$746K	Buy	72,460 +22,093	+44%	+$239K	0.01%	1114
2024 Q1	$631K	Buy	50,367 +5,150	+11%	+$66.6K	﹤0.01%	1084
2023 Q4	$694K	Buy	45,217 +31,831	+238%	+$445K	﹤0.01%	946
2023 Q3	$196K	Buy	13,386 +3,182	+31%	+$49.6K	﹤0.01%	1532
2023 Q2	$181K	Buy	+10,204	New	+$173K	﹤0.01%	1693
2022 Q4	–	Sell	-10,239	Closed	-$195K	–	2118
2022 Q3	$195K	Buy	+10,239	New	+$207K	﹤0.01%	1649
2021 Q3	–	Sell	-21,867	Closed	-$615K	–	2613
2021 Q2	$615K	Buy	+21,867	New	+$582K	0.01%	1253
2021 Q1	–	Sell	-30,541	Closed	-$571K	–	2591
2020 Q4	$571K	Sell	30,541 -2,630	-8%	-$47.3K	0.01%	1168
2020 Q3	$514K	Buy	+33,171	New	+$511K	0.01%	998
2019 Q3	–	Sell	-10,837	Closed	-$239K	–	1635
2019 Q2	$239K	Buy	+10,837	New	+$251K	0.01%	812

Other funds holding TBI

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACM

Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Michael Gelband's TBI Position: Q3 2024 in Review

Michael Gelband sold out of Trueblue (TBI) in Q3 2024, closing a stake of 72,460 shares — an estimated $746K sold.

Michael Gelband first reported a position in TBI in Q2 2019 and held it in 10 quarters. The position peaked at $746K in Q2 2024. 112 funds tracked by Wall St. Rank hold TBI as of Q3 2024.

Michael Gelband reported no remaining Trueblue position as of Q3 2024 after selling out during the quarter.
Michael Gelband sold 72,460 Trueblue shares in Q3 2024, an estimated $746K.
Michael Gelband first reported a position in Trueblue in Q2 2019 and held it in 10 quarters.
Michael Gelband's Trueblue position peaked at $746K in Q2 2024.
112 funds tracked by Wall St. Rank held Trueblue as of Q3 2024.

Based on ExodusPoint Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.